This Science News Wire page contains a press release issued by an organization and is provided to you "as is" with little or no review from Science X staff.

Warning sign for potential anti-cancer approach

March 9th, 2010

One treatment being investigated as an adjuvant for anticancer immunotherapies is the use of molecules that trigger the proteins TLR7 and TLR8. For example, the TLR7 stimulant imiquimod is used for the treatment of skin cancer and metastatic melanoma. However, new research, performed by Isabelle Cremer and colleagues, at INSERM U872, Paris, suggests that such approaches should be developed with caution because stimulation of human lung cancer cells with TLR7 or TLR8 agonists increased tumor cell survival and resistance to chemotherapeutics.

View this article at: www.jci.org/articles/view/3655 … 055913a0375e802e2994

Provided by Journal of Clinical Investigation

Citation: Warning sign for potential anti-cancer approach (2010, March 9) retrieved 20 August 2026 from https://sciencex.com/wire-news/29600935/warning-sign-for-potential-anti-cancer-approach.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.